Financial Services Commission investigates Shin Poong Pharm on charges of 'unfair trade'

Reporter Paul Lee / approved : 2023-09-22 07:01:01
  • -
  • +
  • 인쇄

 

[Apha Biz=(Chicago) Reporter Paul Lee] The Financial Services Commission has launched a forced investigation into Shinpoong Pharmaceutical to check for unfair stock trading by its executives and employees.

According to the financial investment industry on the 21st, the Financial Services Commission's capital market investigation team conducted an on-site survey of the Shin Poong Pharm headquarters earlier in the day.

Forced investigation is a method of investigation that includes on-site investigation, seizure of data (temporary custody), restoration and analysis of smartphone and hard disk (forensics).

It can quickly respond to stock price manipulation as it can conduct an investigation equivalent to a seizure search without having to go through a court warrant process.

The Financial Services Commission is looking into allegations that executives and employees of Shinpung Pharmaceutical Co. traded stocks using unknown internal information in the market in the process of a surge in Shin Poong Pharm's stock prices in recent years.

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

주요기사

Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions2025.09.19
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response2025.09.19
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group2025.09.19
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties2025.09.19
Korea Zinc to Cancel All Treasury Shares by Year-End, Targeting Shareholder Return Ratio Above 200%2025.09.19
뉴스댓글 >

HEADLINE

건강이 보이는 대표 K Medical 뉴스

PHOTO

많이 본 기사